Nucleoside antibiochemotherapy repressed the growth, chemoresistance, survival, and metastatic potentials of castration-resistant prostate cancer cells
S. O. Oseni, G. A. Laguer, F. Ambrin, M. Philemy, J. Betty, J. Kumi-Diaka
This study shows that puromycin and blasticidin inhibit mCRPC cell growth, survival, and metastasis, with synergistic effects when combined with taxanes.
bioRxiv · Aug 22, 2021 · PreprintCancer Biology